









Markets
/
Stocks
/
nasdaq-tcrx
/

TScan Therapeutics Inc

TCRX

1.710USD

+0.090+5.56%

Close 08/04, 16:00（ET）Quotes delayed by 15 min

96.77MMarket Cap

LossP/E TTM



TScan Therapeutics Inc

1.710

+0.090+5.56%

Overview Company Financials

Overview

Company

Financials

Statements

Income Statement

Balance Sheet

Cash Flow Statement

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-28.42%-37.59M

-15.34%-27.41M

-448.24%-27.92M

-19.09%-26.23M

-24.08%-29.27M

-48.44%-23.77M

147.15%8.02M

-64.75%-22.02M

-17.21%-23.59M

-11.34%-16.01M

-24.65%-17.00M

-24.93%-13.37M

-102.11%-20.12M

-95.65%-14.38M

-135.62%-13.64M

-170.19%-10.70M

-94.13%-9.96M

---7.35M

---5.79M

--15.24M

---5.13M

Net income from continuing operations

-13.22%-34.13M

-82.58%-35.81M

-29.96%-29.89M

-31.67%-31.66M

-33.59%-30.14M

-4.75%-19.61M

-41.56%-23.00M

-59.27%-24.05M

-39.66%-22.56M

-31.85%-18.72M

-2.56%-16.25M

-41.44%-15.10M

-104.20%-16.16M

-81.89%-14.20M

-120.91%-15.84M

-90.17%-10.67M

-42.89%-7.91M

---7.81M

---7.17M

---5.61M

---5.54M

Operating gains losses

-45.93%678.00K

-44.45%711.00K

-20.14%1.03M

-13.89%1.12M

-16.34%1.25M

-13.75%1.28M

2.80%1.29M

7.37%1.30M

25.44%1.50M

29.95%1.48M

18.47%1.25M

82.60%1.21M

154.80%1.20M

188.38%1.14M

205.20%1.06M

148.50%661.00K

111.26%469.00K

--396.00K

--346.00K

--266.00K

--222.00K

Other non-cash items

-181.90%-1.28M

45.04%-460.00K

-538.72%-1.50M

---393.00K

---453.00K

---837.00K

---235.00K

----

Change in working capital

-202.70%-6.38M

184.85%5.26M

-100.98%-279.00K

407.03%2.18M

45.70%-2.11M

-2082.39%-6.20M

961.10%28.40M

-41.92%-711.00K

36.81%-3.88M

86.51%-284.00K

-1378.29%-3.30M

57.90%-501.00K

-115.08%-6.15M

-2214.29%-2.11M

-71.52%258.00K

-105.81%-1.19M

-3910.67%-2.86M

---91.00K

--906.00K

--20.47M

--75.00K

-Change in receivables

----

--31.93M

---31.93M

----

-Change in prepaid expenses

-305.49%-524.00K

904.08%394.00K

-68.88%-1.17M

-100.52%-15.00K

121.61%255.00K

-102.46%-49.00K

53.86%-694.00K

140.33%2.91M

43.97%-1.18M

350.23%1.99M

-83.86%-1.50M

180.61%1.21M

-193.31%-2.11M

143.50%442.00K

-389.82%-818.00K

-1237.12%-1.50M

-366.23%-718.00K

---1.02M

---167.00K

--132.00K

---154.00K

-Change in other current liabilities

-283.57%-2.17M

90.76%-666.00K

73.00%-1.05M

-101.99%-534.00K

85.39%-566.00K

-250.39%-7.21M

-73.59%-3.88M

1095.00%26.86M

-90.09%-3.87M

-8.09%-2.06M

-49.70%-2.24M

-47.33%-2.70M

-56.17%-2.04M

-423.08%-1.90M

-678.65%-1.50M

-109.16%-1.83M

---1.30M

---364.00K

---192.00K

--20.00M

--0.00

Cash from non-recurring investing activities

Cash from operating activities

-28.42%-37.59M

-15.34%-27.41M

-448.24%-27.92M

-19.09%-26.23M

-24.08%-29.27M

-48.44%-23.77M

147.15%8.02M

-64.75%-22.02M

-17.21%-23.59M

-11.34%-16.01M

-24.65%-17.00M

-24.93%-13.37M

-102.11%-20.12M

-95.65%-14.38M

-135.62%-13.64M

-170.19%-10.70M

-94.13%-9.96M

---7.35M

---5.79M

--15.24M

---5.13M

Investing cash flow

Net cash from continuing investing activities

117.30%1.53M

89.34%888.00K

-3.45%1.37M

105.24%862.00K

-15.87%705.00K

-65.94%469.00K

234.67%1.42M

-77.81%420.00K

57.82%838.00K

-37.72%1.38M

-50.29%424.00K

-51.68%1.89M

-82.05%531.00K

59.64%2.21M

-36.49%853.00K

1113.00%3.92M

149.28%2.96M

--1.39M

--1.34M

--323.00K

--1.19M

Capital expenditures

117.30%1.53M

89.34%888.00K

-3.45%1.37M

105.24%862.00K

-15.87%705.00K

-65.94%469.00K

234.67%1.42M

-77.81%420.00K

57.82%838.00K

-37.72%1.38M

-50.29%424.00K

-51.68%1.89M

-82.05%531.00K

59.64%2.21M

-36.49%853.00K

1113.00%3.92M

149.28%2.96M

--1.39M

--1.34M

--323.00K

--1.19M

Net cash flow from disposal of fixed assets

117.30%1.53M

89.34%888.00K

-3.45%1.37M

105.24%862.00K

-15.87%705.00K

-65.94%469.00K

234.67%1.42M

-77.81%420.00K

57.82%838.00K

-37.72%1.38M

-50.29%424.00K

-51.68%1.89M

-82.05%531.00K

59.64%2.21M

-36.49%853.00K

1113.00%3.92M

149.28%2.96M

--1.39M

--1.34M

--323.00K

--1.19M

Net cash flow from investment products

-59.15%15.06M

1083.08%28.18M

-34.98%-80.98M

---32.85M

--36.87M

--2.38M

---59.99M

----

Cash from non-current investing activities

Net cash flow from investing activities

-62.59%13.53M

1326.71%27.29M

-34.09%-82.35M

-7927.62%-33.72M

4415.39%36.16M

238.93%1.91M

-14384.43%-61.41M

77.81%-420.00K

-57.82%-838.00K

37.72%-1.38M

50.29%-424.00K

51.68%-1.89M

82.05%-531.00K

-59.64%-2.21M

36.49%-853.00K

-1113.00%-3.92M

-149.28%-2.96M

---1.39M

---1.34M

---323.00K

---1.19M

Financing cash flow

Cash flow from continuous financing activities

-303.49%-525.00K

240373.68%45.69M

588.10%1.23M

19.10%161.59M

--258.00K

-82.41%19.00K

-100.87%-252.00K

437564.52%135.68M

-100.00%0.00

-10.00%108.00K

-67.85%29.13M

104.52%31.00K

-99.91%88.00K

200.00%120.00K

9060700.00%90.61M

-2738.46%-686.00K

44979.64%99.63M

--40.00K

--1.00K

--26.00K

--221.00K

Net cash flow from debt Issuance/repayment

----

--15.31M

----

--0.00

----

--0.00

--29.35M

----

Net cash flow from common stock issuance/repurchase

----

--0.00

100.00%0.00

-22.23%33.13M

----

--0.00

---186.00K

--42.60M

----

--0.00

----

--0.00

--89.65M

----

Net cash flow from preferred stock issuance/repurchase

----

--0.00

-100.00%0.00

--0.00

--99.73M

--0.00

----

--0.00

Proceeds from stock option exercised by employees

----

1889.47%378.00K

12200.00%1.23M

-73.02%184.00K

--258.00K

111.11%19.00K

100.00%10.00K

2100.00%682.00K

-100.00%0.00

-92.50%9.00K

400.00%5.00K

-50.00%31.00K

-18.52%88.00K

200.00%120.00K

0.00%1.00K

138.46%62.00K

-51.13%108.00K

--40.00K

--1.00K

--26.00K

--221.00K

Proceeds from issuance of warrants

----

--30.00M

100.00%0.00

38.83%128.27M

----

--0.00

---76.00K

--92.39M

----

Net cash flow from other financing activities

---525.00K

----

-100.00%0.00

----

--99.00K

-123.96%-230.00K

100.00%0.00

----

--960.00K

---748.00K

---212.00K

----

--0.00

Net cash from non-recurrent financing activities

Net cash from financing activities

-303.49%-525.00K

240373.68%45.69M

588.10%1.23M

19.10%161.59M

--258.00K

-82.41%19.00K

-100.87%-252.00K

437564.52%135.68M

-100.00%0.00

-10.00%108.00K

-67.85%29.13M

104.52%31.00K

-99.91%88.00K

200.00%120.00K

9060700.00%90.61M

-2738.46%-686.00K

44979.64%99.63M

--40.00K

--1.00K

--26.00K

--221.00K

Net cash flow

Beginning cash balance

32.76%183.72M

-13.78%138.15M

15.58%247.19M

44.62%145.54M

10.66%138.39M

12.56%160.22M

63.71%213.87M

-31.01%100.64M

-24.86%125.06M

-22.18%142.34M

22.33%130.64M

19.47%145.87M

370.34%166.44M

314.93%182.91M

108.53%106.79M

236.69%122.10M

-16.46%35.39M

--44.08M

--51.21M

--36.26M

--42.36M

Current period cash flow changes

-443.60%-24.58M

308.72%45.57M

-103.25%-109.04M

-10.23%101.65M

129.29%7.15M

-26.36%-21.83M

-558.42%-53.65M

843.54%113.23M

-18.76%-24.43M

-4.91%-17.28M

-84.62%11.70M

0.49%-15.23M

-123.72%-20.57M

-89.43%-16.47M

1167.38%76.11M

-202.38%-15.30M

1522.64%86.71M

---8.70M

---7.13M

--14.95M

---6.09M

Ending cash balance

9.34%159.14M

32.76%183.72M

-13.78%138.15M

15.58%247.19M

44.62%145.54M

10.66%138.39M

12.56%160.22M

63.71%213.87M

-31.01%100.64M

-24.86%125.06M

-22.18%142.34M

22.33%130.64M

19.47%145.87M

370.34%166.44M

314.93%182.91M

108.53%106.79M

236.69%122.10M

--35.39M

--44.08M

--51.21M

--36.26M

Free cash flow

-30.52%-39.12M

-16.77%-28.30M

-543.89%-29.29M

-20.70%-27.09M

-22.71%-29.97M

-39.39%-24.23M

137.86%6.60M

-47.06%-22.44M

-18.25%-24.43M

-4.80%-17.39M

-20.24%-17.43M

-4.39%-15.26M

-59.92%-20.66M

-89.94%-16.59M

-103.21%-14.49M

-197.96%-14.62M

-104.50%-12.92M

---8.73M

---7.13M

--14.92M

---6.32M

Currency unit

USD

Audit opinions

KeyAI

